Insights from a Decade of 'Cutting Edge Research in Homeopathy'

E. Rachel Roberts,Angelina J. Mosley,Alexander L. Tournier
DOI: https://doi.org/10.1055/s-0043-1777309
2024-01-31
Homeopathy
Abstract:The Homeopathy Research Institute (HRI) is a UK-based organization, dedicated to generating and communicating high-quality research in homeopathy at an international level. HRI also aims to promote fairness and objectivity in how the evidence for homeopathy is used and evaluated, especially by those who are new to this specialist field. Our biennial research conferences play a key role in achieving these aims. In June 2023, HRI held its fifth conference on the theme: ' Cutting Edge Research in Homeopathy '. Alongside our conference report[1] and abstracts,[2] this guest Editorial provides a timely opportunity to reflect on a decade of HRI conferences and ask not only, 'How has the homeopathy research sector evolved over this period?', but also, 'Where is homeopathy research heading, as we look to the future?'. Ten years ago, at the time of our inaugural conference, there were numerous claims that 'there is no evidence' for homeopathy and 'it's just placebo'. The main aim of HRI Barcelona 2013 was therefore a simple one – to physically demonstrate the existence of homeopathy research; not just the evidence itself, but also the existence of an established community of researchers, affirming its legitimacy as a scientific field.[3] Two years later, the HRI Rome 2015 conference effectively illustrated that the evidence for homeopathy was both increasing in volume and improving in quality[3]; the robust systematic review/meta-analysis of individualised homeopathy by Mathie et al had recently been published in the high impact journal ' Systematic Reviews ', showing that 'gold standard' placebo-controlled double-blind randomized controlled trials (RCTs) could detect a significant difference between the effect of individualised homeopathic medicines and placebo.[4] This meta-analysis was pivotal in moving the 'homeopathy debate' forward – or so one could have expected, according to usual scientific processes. The HRI Malta 2017 [3] conference took a more self-reflective stance, with presentations and discussion focusing on learning from the past, to make future studies even more robust, as the sector continued its clear commitment to building on existing positive findings. By contrast, the unspoken theme during HRI London 2019 was bolder and clear to all who attended: i.e., the direction of evidence had become strong enough for the sector to take the more categorical position that the evidence simply does not support the hypothesis that homeopathy is merely a placebo effect – despite detractors continuing to make this claim.[3] A strong outcome from all HRI conferences has been their importance in building networks, bringing research groups together, and providing a supportive environment for the exchange of ideas. Regrettably, during the COVID pandemic the HRI conference was forced to become a virtual event, and while researchers around the world were temporarily forced to work in isolation from one another, our chosen theme for HRI Online 2022 was the tangible positive impacts resulting from international collaboration.[3] The feedback we received confirmed HRI Online 2022 to be a great success, particularly in terms of reaching new audiences who had not attended our previous European-based events due to distance. However, the limitations of the online conference model were also confirmed for the HRI team; sitting alone watching carefully worded public presentations online is no substitute for 21⁄2 days of intensive, in-person exchange, speaking freely about truly novel work and ideas, with colleagues both old and new. For this reason, we were delighted to hold our latest event, HRI London 2023 , in person. As we re-convened after the 4-year hiatus, the sector's maturity was evident.[1] A shift in research focus was also clear, with our earlier conferences emphasizing more clinical studies, while HRI London 2023 placed more emphasis on in vitro experiments, physicochemical approaches, and fundamental research – each of them contributing, from different angles, to the exploration of mode of action of homeopathic medicines. Despite this progression within the homeopathy research field from 2013 to 2023, over this same period the homeopathy debate has remained highly charged: HRI London 2023 was held against a backdrop of persistent refusal from many conventional scientists to accept that homeopathy is rapidly becoming an increasingly evidence-based discipline. Notably, in the lead-up to this most recent conference, Sigurdson et al[5] published a paper confirming that clinical trials do indeed show homeopathy has beneficial effects beyond placebo – but the au -Abstract Truncated-
integrative & complementary medicine
What problem does this paper attempt to address?